Related Experiment Video
Updated: Feb 4, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
[DISBIOTIC AND IMMUNOLOGICAL CHANGES OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ITS COMBINATION WITH
Abstract:
Studied indicators microflora and immune parameters in 75 patients with chronic obstructive pulmonary disease (COPD). Of these, 54 - COPD with arterial hypertension, at 21-isolated leaking COPD. The degree of dysbiosis evaluated on caseinolitic activity feces, immune status - by performance of leukogram and immunograms at determining the levels of CD3+-, CD4+-, CD8+-, CD19+-cells, Ig A, Ig M, Ig G, NST-test. For most COPD patients with hypertension compared with patients with COPD characterized by more pronounced dysbiosis, inflammatory syndrome, the weakening of the functioning of cellular immunity, increased tension of humoral immunity and changed reactions in phagocytic immunity. Disbiotic and immune changes increase with increasing the degree of hypertension from I to III.
Insights
Chronic obstructive pulmonary disease (COPD) patients with arterial hypertension exhibit worsened dysbiosis and immune dysfunction. These changes correlate with the severity of hypertension, impacting cellular, humoral, and phagocytic immunity.
Area of Science:
- Immunology
- Pulmonology
- Microbiology
Background:
- Chronic obstructive pulmonary disease (COPD) is often comorbid with arterial hypertension.
- The interplay between COPD, arterial hypertension, and immune system dysregulation requires further investigation.
Purpose of the Study:
- To investigate microflora and immune parameters in patients with COPD, differentiating between isolated COPD and COPD with arterial hypertension.
- To assess the impact of hypertension severity on dysbiotic and immune profiles in COPD patients.
Main Methods:
- Evaluated fecal caseinolitic activity for dysbiosis.
- Assessed immune status via leukogram, immunogram, CD3+, CD4+, CD8+, CD19+ cell levels, Ig A, Ig M, Ig G, and NST-test.
- Compared immune and microflora indicators between COPD patients with and without hypertension, and across hypertension severity grades (I-III).
Main Results:
- COPD patients with arterial hypertension showed more pronounced dysbiosis and inflammatory syndrome compared to those with isolated COPD.
- Weakened cellular immunity, heightened humoral immunity, and altered phagocytic immunity were observed in COPD patients with hypertension.
- Dysbiotic and immune alterations intensified with increasing hypertension severity from grade I to III.
Conclusions:
- Arterial hypertension exacerbates dysbiosis and immune dysregulation in COPD patients.
- Hypertension severity is directly associated with the degree of microfloral and immune system impairment in COPD.
- Findings highlight the need for integrated management of COPD and arterial hypertension, considering immune and microfloral status.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

